... profits and IVol in Arena et al. (2008) remains consistent with our study, we differ on several points from other studies of investment strategies that are receiving attention in South Korea. Although studies on these trading strategies generally show no momentum profits in South Korea...

... benchmark will have a positive (negative) GHM. Graham and Harvey (1997) examined the performance of 326 investments newsletters during the 1983‐1994 time period. The objective of these newsletters is to offer investor advice on how to time the market, i.e. how to rebalance their portfolio in order...

... effectiveness of investment in R&D is seldom demonstrated explicitly by the literature, and to the best of our knowledge, there are no existing studies on R&D productivity taking an international approach. Many surveys have evidenced the contribution of R&D to corporate growth and performance...

... and then holding period returns of all stocks in the portfolio were computed as the equally‐weighted average portfolio return. © Emerald Group Publishing Limited 2006 Investments Asset valuation Financial markets Price optimism has been evident at certain points in time as depicted...

... diversified, with a mean DDR of 1.76, and firms are somewhat R&D commercial, with a mean COMMER of 4.55. An average firm invests annually $191.64 million developing 18.72 drug indications targeting about 10 diseases. On average, beta is 0.95, book‐to‐market ratio is 0.28, and financial leverage is 1.88. R...